Gareth Bond

Publications

  1. 2019
  2. Published
  3. Published

    Comprehensive landscape of active deubiquitinating enzymes profiled by advanced chemoproteomics

    Gareth Bond, 29 Aug 2019, In: Frontiers in Chemistry. 7, p. 1-14 14 p., 592.

    Research output: Contribution to journalArticlepeer-review

  4. Published
  5. Published
  6. Published

    Venous identity requires BMP signalling through ALK3

    Gareth Bond, 28 Jan 2019, In: Nature Communications. 10, p. 1-18 18 p., 453.

    Research output: Contribution to journalArticlepeer-review

  7. 2016
  8. Published

    CD44 SNPrs187115: a novel biomarker signature that predicts survival in resectable pancreatic ductal adenocarcinoma

    Gareth Bond, Dec 2016, In: Clinical Cancer Research. 22, 24, p. 6069-6077 9 p.

    Research output: Contribution to journalArticlepeer-review

  9. Published

    MEF2 transcription factors are key regulators of sprouting angiogenesis

    Gareth Bond & 1 others, , 15 Oct 2016, In: Genes & Development. 30, 20, p. 2297-2309 13 p.

    Research output: Contribution to journalArticlepeer-review

  10. Published

    A polymorphic antioxidant response element links NRF2/sMAF binding to enhanced MAPT expression and reduced risk of parkinsonian disorders

    Gareth Bond, 26 Apr 2016, In: Cell Reports. 15, 4, p. 830-842 13 p.

    Research output: Contribution to journalArticlepeer-review

  11. Published

    The importance of p53 pathway genetics in inherited and somatic cancer genomes

    Gareth Bond, Apr 2016, In: Nature Reviews Cancer. 16, 4, p. 251-265 15 p.

    Research output: Contribution to journalReview articlepeer-review

  12. 2015
  13. Published

    Interaction between p53 mutation and a somatic HDMX biomarker better defines metastatic potential in breast cancer

    Gareth Bond, 15 Feb 2015, In: Cancer Research. 75, 4, p. 698-708 11 p.

    Research output: Contribution to journalArticlepeer-review

  14. 2014
  15. Published

    Radiation-induced apoptosis varies among individuals and is modified by sex and age

    Gareth Bond, Oct 2014, In: International Journal of Radiation Biology. 90, 10, p. 903-908 6 p.

    Research output: Contribution to journalArticlepeer-review

  16. Published

    A polymorphic enhancer near GREM1 influences bowel cancer risk through differential CDX2 and TCF7L2 binding

    Gareth Bond, 21 Aug 2014, In: Cell Reports. 8, 4, p. 983-990 8 p.

    Research output: Contribution to journalArticlepeer-review

  17. Published

    MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysis

    Aug 2014, In: Haematologica. 99, 8, p. 1285-1291 7 p.

    Research output: Contribution to journalArticlepeer-review

  18. Published

    SNPing away at human skin color

    Gareth Bond, 12 Feb 2014, In: Pigment Cell and Melanoma Research. 27, 3, p. 322-323 2 p.

    Research output: Contribution to journalArticlepeer-review

  19. 2013
  20. Published

    A polymorphic p53 response element in KIT ligand influences cancer risk and has undergone natural selection

    Gareth Bond, 10 Oct 2013, In: Cell. 155, 2, p. 410-22 13 p.

    Research output: Contribution to journalArticlepeer-review

  21. 2012
  22. Published

    Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancer

    Gareth Bond, 15 Aug 2012, In: Cancer Research. 72, 16, p. 4074-4084 11 p.

    Research output: Contribution to journalArticlepeer-review